75 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
14 May 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
7:55am
Litigation Reform Act of 1995 and other federal securities laws. These statements are often identified by the use of words such as “on track
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
27 Mar 24
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
7:49am
of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. These statements are often
8-K
EX-99.2
PYXS
Pyxis Oncology Inc
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws
8-K
EX-99.1
rtdezn c5ley7krkchvl
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
8-K
EX-99.1
trubg3s
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
8-K
EX-99.1
eczh7i
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
skr37w
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.2
a9llv 1hyo3s
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-99.1
efthes1toec0eac7as
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
8-K
EX-99.1
wbpijc
7 Nov 23
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
4:44pm
8-K/A
EX-99.1
pnjnbdberkj5ivdqndu
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-99.2
jctz807roivzw3
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
POS AM
EX-4.7
5pejvj
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
8-K
EX-99.1
5k16hyrodwuihusrjh
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
425
931vob82zzj7jesp9l
11 Aug 23
Business combination disclosure
7:26am
8-K
EX-99.1
9c2ktha9 1n8qzudk8
11 Aug 23
Pyxis Oncology Reports Financial Results for Second-Quarter 2023
7:25am